Cellular immunity and memory to respiratory virus infections

Immunologic Research

Volumn 24, Issue 1, 2001, Pages 53-67

  Woodland, D L ^a   Hogan, R J ^a   Zhong, W ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

CTL; Infectious immunity; Memory; Mucosal immunity; Review; T lymphocytes; Virus

Indexed keywords

COAT PROTEIN; VACCINE; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOLOGICAL MEMORY; INFLUENZA VIRUS; LUNG PARENCHYMA; MORBIDITY; MORTALITY; NONHUMAN; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INFLUENZA, HUMAN; MICE; ORTHOMYXOVIRIDAE; RESPIROVIRUS INFECTIONS; SENDAI VIRUS;

EID: 0034963631     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:24:1:53     Document Type: Article

References (99)

1. Trends in infectious diseases mortality in the Unites States
2. Characterization of influenza A/Hong Kong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice
3. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness
4. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong
5. Orthomyxoviruses
6. Serious morbidity and mortality associated with influenza epidemics
7. Parainfluenza viruses
8. Influenza as a zoonosis: How likely is a pandemic?
9. Sendai virus infection in genetically resistant and susceptible mice
10. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice
11. + T cells
12. Mechanism of protective immunity against in fluenza virus infection in mice without antibodies
13. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice
14. + T cells
15. Roles of alpha beta and gamma delta T cell subsets in viral immunity
16. Studies on the immune response and pathogenesis of Sendai virus infection of mice. II. The immunoglobulin class of plasma cells in the bronchial sub-mucosa
17. The role of macrophages in particle translocation from lungs to lymph nodes
18. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: Homing properties rather than initial frequencies are crucial
19. + T cells
20. + T cells requires direct targeting to virus-infected epithelium
21. + T cells in primary and secondary influenza pneumonia
22. + T cells clear influenza virus by perforin or Fas-dependent processes
23. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses
24. + T cell memory
25. The immune response to influenza infection
26. Evolutionary processes in influenza viruses: Divergence, rapid evolution, and stasis
27. Immunity to influenza in man
28. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes
29. Cytotoxic T lymphocyte memory: Role in cross-protective immunity against influenza?
30. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity
31. +) cytotoxic T lymphocyte responses induced in mucosa-associated tissues
32. Induction of partial specific hetertotypic immunity in mice by a single infection with influenza A virus
33. Cross-protection in mice after immunization with H2N2, H3N2, and Heq2Neq2 influenza virus strains
34. Effects of cell mediated immunity in influenza virus infection in mice
35. + T cells is inefficient in the absence of B cells
36. + T-cell mechanisms in the control of respiratory virus infections
37. Role of the B-cell response in recovery of mice from primary influenza virus infection
38. + T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells
39. Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses
40. Individuals infected with two subtypes of influenza A virus in the same season
41. Effects of immunity on transmission of influenza: Experimental studies
42. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes
43. Cytotoxic T lymphocytes specific for influenza virus
44. Heterotypic immune mice lose protection against influenza virus infection with senescence
45. On immunological memory
46. + T-cell memory to viruses
47. T cell memory
48. Immunological memory and protective immunity: Understanding their relation
49. Kinetics of the response of naive and memory CD8 T cells to antigen: Similarities and differences
50. + memory T cells
51. + T cell response
52. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes
53. Phenotypic analysis of antigen-specific T lymphocytes
54. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
55. +) T-cell memory is induced by Sendai virus infection of mice
56. Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins
57. + memory T cells specific for a subdominant epitope following Sendai virus infection
58. The generation and maintenance of memory T and B cells
59. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"?
60. + T cells during an acute virus infection
61. On the role of antigen in maintaining cytotoxic T-cell memory
62. Differentiation of naive CTL to effector and memory CTL: Correlation of effector function with pheno-type and cell division
63. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection
64. Immunological memory
65. Viral immune evasion due to persistence of activated T cells without effector function
66. + memory T cells
67. Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations
68. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection
69. Activation induces rapid and profound alterations in the trafficking of T cells
70. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein
71. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G
72. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus
73. Distinct types of lung disease caused by functional subsets of antiviral T cells
74. + T cells
75. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection
76. + T cell memory to Sendai virus elicited by DNA vaccination
77. + T-cell memory determined by clonal burst size
78. Outcome of influenza infection: Effect of site of initial infection and heterotypic immunity
79. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization
80. + T cells persist in the lungs following recovery from respiratory virus infections
81. Regulation of T-cell activation in the lung: Isolated lung T cells exhibit surface phenotypic characteristics of recent activation including down-modulated T-cell receptors, but are locked into the G0/G1 phase of the cell cycle
82. Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung
83. Restricted T-cell antigen receptor repertoire in bronchoalveolar T cells from normal humans
84. A common mucosal immunologic system involving the bronchus, breast and bowel
85. Mucosal immunology of the upper respiratory tract
86. The role of nasopharyngeal lymphoid tissue
87. Is BALT a major component of the human lung immune system?
88. Intraepithelial lymphocytes of the intestinal mucosa: Curiouser and curiouser
89. The extrathymic T-cell development pathway
90. Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice
91. A clonal analysis of lung T cells derived by bronchoalveolar lavage of healthy individuals
92. Turnover of naive- and memory-phenotype T cells
93. Induction of bystander T cell proliferation by viruses and type I interferon in vivo
94. Mucosal immunity to HIV-1: Systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A)
95. The adjuvant effect of anon-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide
96. Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides
97. Intranasal immunization with proteoliposomes protects against influenza
98. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes
99. + T cells against influenza virus induced by vaccination with nucleoprotein DNA